$VKTX
-
Markets
Viking Therapeutics Positioned for Growth Amidst Market Dynamics
$VKTX Viking Therapeutics (NASDAQ: VKTX) operates in the biopharmaceutical sector, with a focus on developing therapies for metabolic and endocrine…
Read More » -
Markets
Madrigal Pharmaceuticals Surges Following Competitor’s Disappointing Treatment Results
$VKTX Madrigal Pharmaceuticals saw a significant increase in its stock value on Friday, driven by disappointing results from competitor Novo…
Read More » -
Markets
Viking Therapeutics’ Weight-Loss Pill Trials Show Breakthrough Results, Exceeding Expectations
$VKTX In a significant advancement in obesity treatment, Viking Therapeutics (Nasdaq: VKTX ) has reported remarkable outcomes from its recent…
Read More » -
Markets
Viking Therapeutics: Pipeline Advancements and Competitive Market Position
$VKTX Viking Therapeutics (NASDAQ:VKTX) is preparing to release its Q3 earnings on October 23, with no revenue expected due to…
Read More »